Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -14.10%52.78B | 14.77%221.25B | -4.30%51.61B | -6.11%52.65B | 29.67%55.54B | 53.87%61.45B | 64.75%192.77B | 53.93B | 56.07B | 42.83B |
Cost of revenue | -33.48%22.95B | 7.04%111.24B | -20.84%23.88B | -22.55%24.62B | 27.78%28.24B | 73.71%34.5B | 108.88%103.92B | 30.17B | 31.79B | 22.1B |
Gross profit | 10.70%29.84B | 23.81%110B | 16.71%27.73B | 15.43%28.03B | 31.68%27.3B | 34.24%26.95B | 32.10%88.85B | 23.76B | 24.28B | 20.73B |
Operating expense | 16.20%19.57B | 10.96%74.49B | 7.27%20.16B | 4.28%18.76B | 18.04%18.73B | 16.30%16.84B | 14.18%67.13B | 18.79B | 17.99B | 15.87B |
Operating profit | 1.54%10.27B | 63.56%35.51B | 52.45%7.57B | 47.30%9.27B | 76.20%8.57B | 80.71%10.11B | 156.54%21.71B | 4.96B | 6.29B | 4.86B |
Net non-operating interest income (expenses) | 103M | 172.34%384M | 110.77%137M | 108M | 141M | 65M | ||||
Non-operating interest income | --103M | 172.34%384M | 110.77%137M | --108M | ---- | ---- | --141M | --65M | ---- | ---- |
Net investment income | -52.81%445M | -23.55%1.22B | -19.61%123M | -40.53%-527M | -11.50%685M | -10.10%943M | 171.82%1.6B | 153M | -375M | 774M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | -108.77%-5M | 130.77%4M | 14.29%-6M | 122.73%5M | -446.67%-52M | 5,600.00%57M | -550.00%-13M | -7M | -22M | 15M |
Income before tax | -2.71%10.81B | 58.37%37.12B | 51.14%7.82B | 48.28%8.85B | 65.26%9.34B | 67.20%11.11B | 159.01%23.44B | 5.17B | 5.97B | 5.65B |
Income tax | 2.44%3.23B | 198.83%10.99B | 202.28%1.99B | 421.27%3.85B | 187.07%2B | 99.05%3.16B | 134.20%3.68B | 657M | 738M | 696M |
Net income | -4.75%7.57B | 32.24%26.13B | 29.16%5.83B | -4.32%5.01B | 48.15%7.34B | 57.22%7.95B | 164.21%19.76B | 4.52B | 5.23B | 4.96B |
Net income continuous operations | -4.75%7.57B | 32.24%26.13B | 29.16%5.83B | -4.32%5.01B | 48.15%7.34B | 57.22%7.95B | 164.21%19.76B | --4.52B | --5.23B | --4.96B |
Noncontrolling interests | 0 | 0 | ||||||||
Net income attributable to the company | -4.75%7.57B | 32.24%26.13B | 29.16%5.83B | -4.32%5.01B | 48.15%7.34B | 57.22%7.95B | 164.21%19.76B | 4.52B | 5.23B | 4.96B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -4.75%7.57B | 32.24%26.13B | 29.16%5.83B | -4.32%5.01B | 48.15%7.34B | 57.22%7.95B | 164.21%19.76B | 4.52B | 5.23B | 4.96B |
Gross dividend payment | ||||||||||
Basic earnings per share | -8.94%42.33 | 26.40%148.39 | 21.67%32.6493 | -10.38%27.86 | 40.24%41.2803 | 54.70%46.484 | 164.20%117.4 | 26.8337 | 31.0871 | 29.4352 |
Diluted earnings per share | -5.53%41.83 | 29.88%144.8 | 28.92%32.23 | -11.02%27.66 | 38.03%40.63 | 47.36%44.28 | 150.90%111.49 | 25 | 31.0871 | 29.4352 |
Dividend per share | 0 | 14.29%48 | -40.48%25 | 0 | 23 | 0 | 42 | 42 | ||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |